Mondaq India: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
King, Stubb & Kasiva
The bench consisting of Justice R. Banumati and Justice A.S. Bopanna of Hon'ble Supreme Court of India in judgment dated 30th July 2019, in the matter of Zeninth Drugs & Allied Agencies Pvt. Ltd. v. Nicholas Primal India Pvt. Ltd. ...
S.S. Rana & Co. Advocates
A trademark, by definition, is a word/phrase/symbol/design that is capable of distinguishing the source of the goods and/or services (in relation to which it is used) of one party from another.
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
AMLEGALS
The focus of the regulation is to make the Companies accountable for their claims on food products and cater to the interest of customers.
Nishith Desai Associates
Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
S.S. Rana & Co. Advocates
Since time immemorial, India has been one of the most preferred sources of procuring products for sale in the market worldwide.
S.S. Rana & Co. Advocates
But the treating doctor called back the Complainant only at 10.30 p.m. as she was out of station.
S.S. Rana & Co. Advocates
Cannabis, also known as ‘marijuana' among other names is a psychoactive drug from the Cannabis plant used for medical or recreational purposes.
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
Obhan & Associates
The development of new drug molecules has never been easy and is full of challenges, some of which include the following:
AZB & Partners
On June 20, 2019, CCI penalised Jalgaon District Medicine Dealers Association (‘JDMDA') as well as its office bearers, i.e., the President and Secretary of JDMDA
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
Singh & Associates
It takes at least ten years for a new medicine to complete its journey from initial discovery to marketplace in treating patients.
SKP Business Consulting LLP
India is one of the world's largest seafood producers and top exporter of fish and fish products to the major developed markets of the world such as US
Singh & Associates
FDA Finalizes guidance for premarket tobacco product applications to check oversight of tobacco products and health issue
Singh & Associates
The DG submitted the "Main Investigation Report" upon completion of investigation.
Singh & Associates
Impact of ENDS on Public Health ENDS or e-cigarettes are battery operated smoking devices.
LexOrbis
The US Food and Drug Administration (FDA) has over the years come up with initiatives to protect the interests of both the patented and generic drug manufacturers.
Singh & Associates
On June 17, 2019, a report on ‘The Indian pharmaceutical industry – the way forward' was published by an Indian Pharmaceutical Alliance representing research based pharmaceutical companies ...
Singh & Associates
The Pharmacovigilance Programme of India, was first introduced in the year 2010 to improve safety of Indian population by monitoring drug related Adverse Drug Reactions collected via ADR monitoring centers ...
Latest Video
Most Popular Recent Articles
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Khurana and Khurana
Intellectual property is an intangible form of property while a ‘Patent' is a subset of intellectual property.
Khurana and Khurana
Trademarks play a vital role in creating a brand name and goodwill of any business. Not only does it helps in creating a brand value but also, aids in revenue generation.
Singh & Associates
It takes at least ten years for a new medicine to complete its journey from initial discovery to marketplace in treating patients.
Cyril Amarchand Mangaldas
Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
Obhan & Associates
The development of new drug molecules has never been easy and is full of challenges, some of which include the following:
Nishith Desai Associates
Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with